View of Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

Return to Article Details Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients Download Download PDF